Literature DB >> 23435414

Dynamic analysis of modified transcutaneous lower blepharoplasty based on biochemical and biophysical principles.

Chuh-Kai Liao1, Feng-Chou Tsai, Tsorng-Harn Fong, Chin-Ju Huang, Yi-Chin Shen, Yuan-Hao Ku, Ching-Hua Su.   

Abstract

In this study, we analyzed the key parameters of modified transcutaneous lower blepharoplasty based on multidisciplinary principles (biochemical findings and biophysical wrinkling theory). A total of 408 female patients received our subciliary lower blepharoplasty between March 2002 and January 2010. The severity of the eyebags (dynamic wrinkle numbers and prolapse) was evaluated through preoperative and postoperative photography, whereas the excised lower eyelid skin specimens from 56 patients were investigated with hematoxylin and eosin staining. The modified techniques produced significant improvements in the severity of eyebags in all age groups (P < 0.001). Poor surgical outcome was found to correlate significantly with preoperative dynamic wrinkle numbers (P < 0.001). Age, dynamic wrinkle numbers, and prolapse correlated significantly with dermal fiber density (P = 0.004, 0.000, and 0.000, respectively) but not epidermal, rete ridge, and dermal thickness or the number of rete ridges. In conclusion, modified transcutaneous lower blepharoplasty provides significant improvement to dynamic wrinkles and prolapse in the eyebags. Periorbital aging progressively disturbs the dermal compactness (fiber density) until the structure can no longer hold its integrity at the critical age (around the age of 40).

Entities:  

Mesh:

Year:  2013        PMID: 23435414     DOI: 10.1097/SAP.0b013e3182583f1a

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  1 in total

1.  Damage from periorbital ageing to the multilayered structures and resilience of the skin in Chinese population.

Authors:  Chuh-Kai Liao; Feng-Chou Tsai; Tsorng-Harn Fong; Chien-Ming Hu; Po-Li Wei; Ching-Hua Su
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.